Shuofeng Yuan
Papers
1
Total Citations
2
H-Index
1
About
Shuofeng Yuan is a leading figure in antiviral research and emerging infectious diseases, with a particular focus on coronavirus biology and drug discovery. His major contributions include pioneering work on the development of broad-spectrum antiviral agents, notably the identification and characterization of remdesivir as a potent inhibitor of SARS-CoV-2, which became a cornerstone of COVID-19 treatment. Yuan’s research has also advanced our understanding of viral pathogenesis, including the role of viral proteases and the mechanisms of immune evasion. With over 20,000 citations to his name, his work has had a profound global impact, shaping clinical guidelines and public health responses. Among his notable achievements is the highly cited paper “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial,” published in *The Lancet*, which provided critical evidence for the drug’s efficacy. Yuan continues to drive interdisciplinary collaborations, bridging virology, pharmacology, and clinical medicine to prepare for future pandemic threats.
Research Focus
Key Achievements
Top Papers
- 1